Logo
x

Search

Subscribe Now

Canada

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

  • August 24, 2021
Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk Acute Myeloid Leukemia

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...

  • July 9, 2021
Celltrion Launches Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis in Canada

Celltrion Launches Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis in Canada

  • June 7, 2021
Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

  • May 19, 2021
Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada

Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada

  • May 17, 2021
Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

  • April 15, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.